The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Contract Dispute Arbitration for a publicly traded supplier of industrial parts
Represented a publicly traded supplier of industrial parts in the successful arbitration of a significant breach of contract dispute against one of more
Wrongful death litigation for a pro bono client
Represented a widow in a wrongful death suit against a railroad company arising from the derailment of an Amtrak passenger train in South Carolina. A more
Health and welfare employee benefits for a national beverage manufacturer
Represented a national beverage manufacturer in conducting an ERISA, COBRA and HIPAA privacy and security compliance audit of its health and welfare more
Reservoir dispute for large municipality
Represented large municipality with regard to the challenge of a potential new reservoir, which would have the effect of removing the city’s existing more